Tatiana Schlossberg revealed that she has terminal cancer in an essay published Nov. 22. In the same essay, she slammed her ...

Breakthrough universal cancer vaccine using mRNA technology enters human trials, potentially working against all cancer types ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

Despite the success of immune checkpoint inhibitors in revolutionizing oncology, their benefits remain limited to a small ...

Cancer vaccines have long sounded like science fiction, but a new wave of nanoparticle research is pushing that idea closer ...

A new generation of personalized cancer vaccines is taking shape through the use of neoantigen-based dendritic cell (DC) ...

Arginase 1 (Arg1) is a key mediator of immune suppression, and its overexpression has been reported in multiple cancers, including renal cell carcinoma, pancreatic cancer, and head and neck cancer.

Maina Modu, an immunization officer in Nigeria’s northeastern Borno state, lost his wife, Hauwa, to cervical cancer in 2011.

SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma.

Scientists are increasingly looking at mRNA vaccines for cancer, not just viruses. The results of a study published in the journal Nature in October showed the promise of mRNA vaccines in fighting ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer. The work still requires ...

The work still requires validation, but the strength of the signal in the study — which analyzed differences in outcomes between cancer patients who did and did not receive mRNA vaccinations during ...